Navigation Links
Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
Date:10/5/2011

NEW YORK, Oct. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers

http://www.reportlinker.com/p0651433/Global-Cardiovascular-Drug-Market-Strategic-Assessments-of-Leading-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Global Cardiovascular Drug Market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:

• Sales forecast for major product segments: ethical, OTC, generics.

• Sales forecast for major drug categories.

• Sales forecasts by geographical region: North America, Europe, Japan, Latin America.

In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.

The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report's major objectives include:

• To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the global cardiovascular drug market.

• To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors.

• To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.

• To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

Contains 1,353 pages and 127 tables

Table of Contents

Abbott

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

AstraZeneca

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Bristol-Myers Squibb

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Eli Lilly

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionGlaxoSmithKline

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Johnson & Johnson

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Merck

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Novartis

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionPfizer

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Roche

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Sanofi-Aventis

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Wyeth

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionList of Tables

Abbott Sales and Operating Profit Growth

Abbott Sales by Therapeutic Category/Business

Abbott Sales Growth by Therapeutic Category/business

Abbott Sales by Major Drug/Business

Abbott Sales Growth by Major Drug/Business

Abbott Sales by Major Drug/Business and Geographic Region

Abbott Sales by Geographic Region and Country

Abbott Sales Growth by Geographic Region and Country

AstraZeneca Sales and Operating Profit Growth

AstraZeneca Sales by Therapeutic Category/Business

AstraZeneca Sales Growth by Therapeutic Category/business

AstraZeneca Sales by Major Drug/Business

AstraZeneca Sales Growth by Major Drug/Business

AstraZeneca Sales by Major Drug/Business and Geographic Region

AstraZeneca Sales by Geographic Region and Country

AstraZeneca Sales Growth by Geographic Region and Country

Bristol-Myers Squibb Sales and Operating Profit Growth

Bristol-Myers Squibb Sales By Major Drug and Geographic Region

Bristol-Myers Squibb Sales Growth by Major Drug

Bristol-Myers Squibb Sales By Geographic Region

Bristol-Myers Squibb Estimated Sales Growth By Geographic Region

Historical Financials

Bristol-Myers Squibb Sales and Operating Profit growth

Bristol-Myers Squibb Sales by Major Division

Bristol-Myers Squibb Sales by Major Division and Geographic Region

Bristol-Myers Squibb Sales Growth by Major Division

Bristol-Myers Squibb Sales by Therapeutic Category

Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region

Bristol-Myers Squibb Sales Growth by Therapeutic Category

Bristol-Myers Squibb Sales by Major Drug

Bristol-Myers Squibb Sales Growth by Major Drug

Bristol-Myers Squibb Sales by Product Line

Bristol-Myers Squibb Sales Growth by Product Line

Bristol-Myers Squibb Sales by Geographic Region

Bristol-Myers Squibb Sales Growth by Geographic Region

Bristol-Myers Squibb Other Health Care Sales by Product

Bristol-Myers Squibb Sales Growth by Geographic Region

Eli Lilly Sales and Operating Profit Growth

Eli Lilly Sales by Therapeutic Category

Eli Lilly Sales Growth by Therapeutic Category

Eli Lilly Sales by Major Product

Eli Lilly Sales Growth by Major Drug

Eli Lilly Sales by Geographic Region

Eli Lilly Sales Growth by Geographic Region

Eli Lilly Sales and Operating Profit Growth

GlaxoSmithKline Sales by Business Segment

GlaxoSmithKline Sales Growth by Business Segment

GlaxoSmithKline Operating Profit and Margins by Business Segment

GlaxoSmithKline Operating Profit by Business Segment GlaxoSmithKline Sales and Operating Profit Growth

GlaxoSmithKline Sales by Major Drug

GlaxoSmithKline Sales by Drug and Geographic Region

GlaxoSmithKline Sales by Therapeutic Category

GlaxoSmithKline Sales Growth by Therapeutic Category

GlaxoSmithKline Sales by Geographic Region and Country

GlaxoSmithKline Sales Growth by Geographic Region

GlaxoSmithKline Consumer Healthcare Sales by Product Line

GlaxoSmithKline Consumer Healthcare Sales Growth By Product Line

Johnson & Johnson Sales by Geographic Region and Country

Johnson & Johnson Sales Growth by Geographic Region

Johnson & Johnson Sales by Business Segment and Geographic Region

Johnson & Johnson Sales and Operating Profit Growth

Johnson & Johnson Sales by Major Drug

Johnson & Johnson Pharmaceutical Sales Growth by Major Drug

Johnson & Johnson Consumer Segment Sales by Product Line

Johnson & Johnson Consumer Segment Sales Growth by Product Line

Merck Sales and Operating Profit Growth

Merck Sales by Geographic Region

Merck Sales Growth by Geographic Region

Merck Sales by Therapeutic Category

Merck Sales Growth by Therapeutic Category

Merck Sales by Major Drug

Merck Sales Growth by Major Drug

Merck Sales by Major Drug and Geographic Region

Novartis Sales and Operating Profit Growth

Novartis Sales by Business Segment

Novartis Sales Growth by Business Segment

Novartis Operating Profit by Business Segment

Novartis Operating Profit Growth by Business Segment

Novartis Sales by Country

Novartis Sales Growth by Country

Novartis Sales by Therapeutic Category

Novartis Sales Growth by Therapeutic Category

Novartis Sales of Top 20 Drugs

Novartis Sales Growth by Major Drug

Pfizer Sales by Division

Pfizer Sales and Operating Profit Growth

Pfizer Sales by Therapeutic Category

Pfizer Sales by Major Product

Pfizer Sales Growth by Major Product

Pfizer Sales by Geographic Region

Pfizer Sales Growth by Geographic Region

Roche Sales and Operating Profit Growth

Roche Sales by Major Division

Roche Sales Growth by Business Segment

Roche Sales by Geographic Region

Roche Sales Growth by Geographic Region

Roche Sales and Operating Profit Growth

Roche Sales by Division

Roche Operating Profit by DivisionRoche Operating Profit Growth by Division

Roche Sales by Therapeutic Category

Roche Sales of Top 20 Products

Sanofi-Aventis Sales and Operating Profit Growth

Sanofi-Aventis Sales by Business Segment

Sanofi-Aventis Sales Growth by Business Segment

Sanofi-Aventis Sales of Top 15 Drugs

Sanofi-Aventis Sales Growth of Top 15 Drugs

Sanofi-Aventis Sales of 15 Major Drugs and Geographic Region

Sanofi-Aventis Sales by Geographic Region

Sanofi-Aventis Vaccine Sales by Major Product

Wyeth Sales by Business Segment

Wyeth Sales Growth by Business Segment

Wyeth Sales and Operating Profit Growth

Wyeth Sales by Therapeutic Category

Wyeth Sales by Major Drug

Wyeth Consumer Healthcare Sales by Product

Wyeth Consumer Healthcare Sales Growth by Product

To order this report:

Drug and Medication Industry: Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers

Drug and Medication Business News

More  Industry Analysis and Insights

CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Global CNS Drug Market: Strategic Assessments of Leading Suppliers
2. Global Oncology Drug Market: Strategic Assessments of Leading Suppliers
3. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
4. Intelsius Hires New Chief Financial Officer to Manage Continued Global Growth
5. GlaxoSmithKline Donates Scientific Equipment to Advance IDRIs Global Health Mission
6. Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary
7. FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet
8. Global Radiation Therapy Equipment Industry
9. Global Medical Specialty Bags Industry
10. Top 1000 Pharmaceutical Wholesalers (Global)
11. Top 450 Biotechnology (Pharmaceuticals) Report (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... CAMBRIDGE, England , May 25, 2016 /PRNewswire/ ... genomics company employing the precision of circulating tumour ... oncology, today announces the appointment of Professor ... will provide medical leadership across the clinical development ... that Inivata,s products help deliver significant improvements in ...
(Date:5/24/2016)... 24, 2016 Cirujanos holandeses han ... a los médicos a compartir sus mejores prácticas por ... mundial. Profesionales médicos de Europa, África, Asia ... a la aplicación, que combina la transmisión en vivo ... seguro. Educación   "Imagine un médico ...
(Date:5/24/2016)... May 24, 2016  Diana Russell suffers from a ... from the inside out.  This disease has put her ... her children and grandchildren to leave her home.  Because ... family cannot haul the wheelchair.  So if there is ... and Diana is left to wait for the bus. ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... , ... After a year and a half of planning the Multiple Pathways of Recovery ... Pathways of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott ... together to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... This ... of a stroke, which we as a society can control and change. , As ... occurs nearly every 40 seconds within the United States. Plus, with an estimated 129,000 ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
Breaking Medicine News(10 mins):